Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore practical guidance on the first crypto to buy as a beginner, including risk considerations and a simple decision framework.
26,337 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Jim Cramer says he cringes at owning AT&T or Verizon as Bernstein flags Starlink competition risk, signaling a potent...
With a 2022 packaging law moving recycling costs onto producers, California starts collecting fees this summer. Regul...
Brenda Fricker’s storied career shows more than artistic talent — it offers lessons on money resilience. This article...
Jamie Dimon argues that insecurity is the real career killer for CEOs as they move from specialists to generalists. T...
NVIDIA is broadening beyond GPUs into physical AI robotics, building a global ecosystem and securing China sales, as ...
Retirement is more than budgeting for groceries and utilities. This guide reveals three hidden costs retirees often m...
Milan rolls out a modern Olympic stadium and hundreds of new homes, a move officials say primes the city for sustaine...
The AI inference market could surge to about $255 billion by 2030 as demand for real-time AI services climbs. Learn w...
A high-profile moment shows how a single statement can ripple into your wallet. This article breaks down the financia...
March trading action kept pushing higher as Plug Power surged again, helping to lead a broader market rally. This art...
Oil prices have spiked more than 25% since the conflict began, but oil stocks have barely moved. This guide explains ...